Skip to main content
Fig. 5 | Cancer & Metabolism

Fig. 5

From: Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states

Fig. 5

Pathway analysis integrating expression differentials from KS transcriptomics with differential polar metabolites between KS and KSHV + HIV + individuals. For visualization purposes, the authors have focused on pathways in which both genes and metabolites were identified for the purpose of linking metabolic and gene expression phenotypes. A Pathway analyses were completed using the MetaboAnalyst Joint Pathway Analysis tool in MetaboAnalyst v5.0 [27]. For metabolomics data, identified metabolites with a minimum FC of 2 (FC > 2 or < 0.5) and a raw p-value < 0.05 were used for pathway analyses. Included transcriptomics data was derived from a previously published report in which the transcriptomic profile of healthy skin was compared to cutaneous KS lesions [14]. B A summary of significantly changed genes and metabolites within central carbon, purine, and urea metabolism is depicted. Genes and metabolites related to lipid metabolism have not been included due to redundancy and space limits. Red- and blue-colored boxes indicate increased and decreased detection, respectively, while gray boxes indicate metabolites that were detected in this study but were not significantly different. Genes are bold and italicized

Back to article page